These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22264563)

  • 1. Identification and characterization of three impurities in clocortolone pivalate.
    Xu W; Jia X; Liu W; Zhang X; Chen Y; Zhou L; You S
    J Pharm Biomed Anal; 2012 Mar; 62():167-71. PubMed ID: 22264563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clocortolone pivalate: a topical corticosteroid with a unique structure.
    Kircik LH
    J Drugs Dermatol; 2013 Feb; 12(2):s3-4. PubMed ID: 23377404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using complementary mass spectrometric approaches for the determination of methylprednisolone metabolites in human urine.
    Pozo OJ; Marcos J; Matabosch X; Ventura R; Segura J
    Rapid Commun Mass Spectrom; 2012 Mar; 26(5):541-53. PubMed ID: 22302494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
    Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of potential impurities of donepezil.
    Krishna Reddy KV; Moses Babu J; Kumar PA; Chandrashekar ER; Mathad VT; Eswaraiah S; Reddy MS; Vyas K
    J Pharm Biomed Anal; 2004 Sep; 35(5):1047-58. PubMed ID: 15336352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS
    J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.
    Cao X; Tai Y; Sun C; Wang K; Pan Y
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):39-45. PubMed ID: 16085133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of related impurities in megestrol acetate.
    Guo F; Feng H; Wang Y; Zhang C; Li Y
    J Pharm Biomed Anal; 2006 Jun; 41(4):1418-22. PubMed ID: 16616448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, isolation and characterization of potential degradation products in pioglitazone hydrochloride drug substance.
    Ramulu K; Kumar TT; Krishna SR; Vasudev R; Kaviraj M; Rao BM; Rao NS
    Pharmazie; 2010 Mar; 65(3):162-8. PubMed ID: 20383934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR.
    Raman B; Sharma BA; Mahale G; Singh D; Kumar A
    J Pharm Biomed Anal; 2011 Sep; 56(2):256-63. PubMed ID: 21664089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of new impurities in rivastigmine.
    Srinivasa Rao M; Rao SV; Srinivasa Rao DV; Bharathi Ch; Rajput P; Sharma HK
    Pharmazie; 2010 May; 65(5):336-8. PubMed ID: 20503924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structure elucidation of butyl 6alpha-fluoro-11beta-hydroxy-16alpha-methyl-3,20-dioxo-1,4-pregnadien-21-oate (fluocortin butylester) (author's transl)].
    Cleve G; Frost E; Hoyer GA; Rosenberg D; Seeger A
    Arzneimittelforschung; 1977; 27(11a):2188-91. PubMed ID: 580027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
    J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN; Maurya PK; Raju AN
    J Pharm Biomed Anal; 2009 Jul; 49(5):1287-91. PubMed ID: 19376664
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.